Mechanisms of group B streptococcal interactions with extraplacental membranes
Mechanisms of group B streptococcal interactions with extraplacental membranes
批准号:
8507835
负责人:
David M Aronoff
金额:
$59.61万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-01 至 2013-09-30
关键词:
AttentionBacterial InfectionsBehaviorCellsCessation of lifeChildChildhoodCollaborationsCommunicable DiseasesDataDevelopmentDiseaseFemaleFutureGene ExpressionGene Expression ProfileGenomeGenotypeGlobal ChangeGoalsHealthHumanImmuneImmune responseImmunologyInfectionInfection of amniotic sac and membranesInflammatory ResponseInvadedInvestigationLightMaternal MortalityMediatingMembraneModelingMolecularMolecular ProfilingMothersNatural ImmunityNeonatal MortalityOutcomePathogenesisPatient currently pregnantPerinatalPerinatal InfectionPhenotypePregnancyPregnant UterusPregnant WomenPremature BirthPrevention strategyPreventivePublishingReportingReproductive BiologyResearch PersonnelScienceSepsisShapesStagingStreptococcal InfectionsStreptococcusStreptococcus Group BSystemTestingTherapeuticTissuesVariantVirulenceVisionWomen&aposs Healthbasedisabilityfetal infectionimprovedmacrophagemicrobialmicrobial hostmicroorganism interactionneonatal morbidityneonatenovelplacental membranepreventreproductiveresponsestillbirthtranscriptomics
中文摘要
描述(由申请人提供):妊娠子宫的细菌感染是早产、死产、孕产妇死亡和儿童残疾的主要原因。B群链球菌(GBS)是主要的罪魁祸首,但由于我们对感染的宿主-微生物相互作用的理解不足,推进预防和治疗策略的速度放慢了。我们的长期愿景是通过确定疾病发病机制的分子机制来减轻围产期感染的负担。该项目的目标是新鉴定宿主和侵入性GBS感染的细菌决定因素。系统发育上不同的GBS菌株在新生儿和孕妇中引起疾病的能力存在相当大的差异,从无症状定植到严重感染。这些差异的基础尚不清楚。GBS与母体妊娠组织相互作用的早期阶段可能决定感染的结果。新的数据表明,根据菌株的不同,宿主和细菌对初次接触的反应都有很大差异,但这在母胎感染方面几乎没有得到任何关注。基于我们团队和其他人的初步数据,我们假设:(1)GBS独特的多位点序列类型(STs)中不同的毒力基因表达谱是由接触人类妊娠组织触发的;(2)宿主对GBS的免疫反应是由感染st的毒力塑造的。我们建议通过三个特定目标来验证这些新的假设,利用微生物发病机理、生殖生物学、传染病和先天免疫。目的是:(1)确定不同GBS STs在人胎盘巨噬细胞和完整胎盘外妊娠膜感染期间的整体转录组重塑差异;(2)确定宿主对介导人胎盘外妊娠膜侵袭性和定殖性GBS表型的多种GBS序列类型的免疫反应;(3)确定GBS ST变化对胎盘巨噬细胞行为的影响程度。这些研究将揭示围产期GBS感染的发病机制,揭示可用于改善全世界母亲和儿童健康的新靶点。
英文摘要
DESCRIPTION (provided by applicant): Bacterial infections of the pregnant uterus are major causes of preterm birth, stillbirth, maternal death, and childhood disability. Group B Streptococcus (GBS) is a major culprit, but advancing preventive and therapeutic strategies has been slowed by gaps in our understanding of the host-microbial interactions responsible for infection. Our long term vision is to reduce the burden of perinatal infections by defining molecular mechanisms of disease pathogenesis. The goal of this project is to newly identify host and bacterial determinants of invasive GBS infection. There is considerable variation in the ability of phylogenetically distinct GBS strains to cause disease in neonates and pregnant women, ranging from asymptomatic colonization to severe infection. The basis of these differences is unclear. Early stages in the interaction between GBS and maternal gestational tissues potentially determine the outcome of infection. New data suggest that both host and bacterial responses to initial contact vary significantly depending on the strain, yet this has received almost no attention in regards to maternal-fetal infection. Based on preliminary data from our groups and others, we hypothesize that (1) distinct virulence gene expression profiles in unique multilocus sequence types (STs) of GBS are triggered by contact with human gestational tissues, and (2) host immune responses to GBS are shaped by the virulence of the infecting ST. We propose to test these novel hypotheses through three Specific Aims that take advantage of collaborations among experts in microbial pathogenesis, reproductive biology, infectious diseases, and innate immunity. The Aims are: (1) identify differences in global transcriptome remodeling of diverse GBS STs during infection of human placental macrophages and intact extraplacental gestational membranes; (2) define host immune responses to diverse GBS sequence types that mediate invasive vs. colonizing GBS phenotypes in human extraplacental gestational membranes; and (3) determine the extent to which placental macrophage behavior is influenced by GBS ST variation. These studies will shed new light on the pathogenesis of perinatal GBS infections, revealing novel targets that could be used to improve the health of mothers and children worldwide.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bacterial CRISPR interference to define macrophage responses to group B Streptococcus proteins
-
批准号:10724607
-
项目类别:
-
资助金额:$25.29万
-
财政年份:2023
-
负责人:David M Aronoff
-
依托单位:
The Role of macrophages in chorioamnionitis and group B streptococcal infections
-
批准号:10576123
-
项目类别:
-
资助金额:$26.68万
-
财政年份:2017
-
负责人:David M Aronoff
-
依托单位:
Determining the contribution of zinc deficiency to perinatal Group B Streptococcus infections
-
批准号:10163224
-
项目类别:
-
资助金额:$37.43万
-
财政年份:2017
-
负责人:David M Aronoff
-
依托单位:
The Role of macrophages in chorioamnionitis and group B streptococcal infections
-
批准号:9978691
-
项目类别:
-
资助金额:$47.26万
-
财政年份:2017
-
负责人:David M Aronoff
-
依托单位:
The Role of macrophages in chorioamnionitis and group B streptococcal infections
-
批准号:10211123
-
项目类别:
-
资助金额:$20.58万
-
财政年份:2017
-
负责人:David M Aronoff
-
依托单位:
Determining the contribution of zinc deficiency to perinatal Group B Streptococcus infections
-
批准号:9381886
-
项目类别:
-
资助金额:$54.44万
-
财政年份:2017
-
负责人:David M Aronoff
-
依托单位:
The Role of macrophages in chorioamnionitis and group B streptococcal infections
-
批准号:9403144
-
项目类别:
-
资助金额:$49.55万
-
财政年份:2017
-
负责人:David M Aronoff
-
依托单位:
Prostaglandins as protective mediators in Clostridium difficile infection
-
批准号:9316517
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2016
-
负责人:David M Aronoff
-
依托单位:
Repurposing misoprostol for Clostridium difficile colitis as identified by PheWAS
-
批准号:9336367
-
项目类别:
-
资助金额:$27.65万
-
财政年份:2016
-
负责人:David M Aronoff
-
依托单位:
Epidemiology and Genomics of Clostridium difficile
-
批准号:8026742
-
项目类别:
-
资助金额:$39.15万
-
财政年份:2010
-
负责人:David M Aronoff
-
依托单位:
Role of misoprostol in Clostridium sordellii endometritis after medical abortion
-
批准号:8081862
-
项目类别:
-
资助金额:$31.15万
-
财政年份:2008
-
负责人:David M Aronoff
-
依托单位:
Role of misoprostol in Clostridium sordellii endometritis in a rodent model
-
批准号:8277067
-
项目类别:
-
资助金额:$31.15万
-
财政年份:2008
-
负责人:David M Aronoff
-
依托单位:
Role of misoprostol in Clostridium sordellii endometritis after medical abortion
-
批准号:7680224
-
项目类别:
-
资助金额:$32.68万
-
财政年份:2008
-
负责人:David M Aronoff
-
依托单位:
Role of misoprostol in Clostridium sordellii endometritis after medical abortion
-
批准号:7522413
-
项目类别:
-
资助金额:$32.68万
-
财政年份:2008
-
负责人:David M Aronoff
-
依托单位:
Role of misoprostol in Clostridium sordellii endometritis after medical abortion
-
批准号:7860698
-
项目类别:
-
资助金额:$32.45万
-
财政年份:2008
-
负责人:David M Aronoff
-
依托单位:
Modulation of Lung Innate Immunity by Prostaglandin E2
-
批准号:6849574
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2004
-
负责人:David M Aronoff
-
依托单位:
Modulation of Lung Innate Immunity by Prostaglandin E2
-
批准号:7324116
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2004
-
负责人:David M Aronoff
-
依托单位:
Modulation of Lung Innate Immunity Prostaglandin E2
-
批准号:7533988
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2004
-
负责人:David M Aronoff
-
依托单位:
Modulation of Lung Innate Immunity Prostaglandin E2
-
批准号:6992748
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2004
-
负责人:David M Aronoff
-
依托单位:
Modulation of Lung Innate Immunity by Prostaglandin E2
-
批准号:7151167
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2004
-
负责人:David M Aronoff
-
依托单位:
海外基金